News

VivaGel® BV demonstrated statistically significant efficacy in two pivotal phase 3 trials

VivaGel® BV consistently resulted in reduced rates of BV recurrence by the primary efficacy endpoint and five secondary efficacy measures, and delayed time to first recurrence VivaGel® BV resulted in sustained benefits 3 months after cessation of treatment…

LBT’S Woundvue™ Prototype to be Used at Central Adelaide Health Network

Australian medical technology company LBT Innovations Limited (ASX:LBT) has entered a collaboration agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services, to use LBT’s novel WoundVue™ prototype device in the clinical trial, “Predicting outcomes in…

Clinical Trials in Australia: the economic profile and competitive position of the sector

Clinical trials are an integral part of the research and development of new treatments, interventions or tests, and the refinement of existing standards of care and clinical practices. As such, they are vital to the future of healthcare.…

Bionic vision a step closer with the CSIRO’s new computing system 

People with profound vision loss are one step closer to having their sight effectively restored, thanks to a new investment from Australia’s chief science body into a large-scale scientific computing system. The new Bracewell system, which is being used by Data61’s computer vision group that…

Handy SME Info: TGA SME Assist Hub

Therapeutic goods regulation and legislation can be challenging to navigate. The SME Assist hub is designed to help small and medium enterprises, and R&D groups developing new medicines and medical devices (including apps) understand their regulatory and legislative…

Announcing the Victorian Clinical Trials – Gateway Project!

Victorian Clinical Trials – Gateway is a new digital portal for accessing clinical trial partners in Victoria. St Vincents Hospital Melbourne and the Victorian Government’s Department of Economic Development, Jobs, Training and Resources (DEDJTR) are collaborating to create the Gateway…

State of the Sector Medical Technologies and Pharmaceuticals 2017

Victoria has one of the world’s largest life science clusters composed of the medical technology (medtech), biotechnology (biotech) and pharmaceutical industries. It is home to a vibrant commercial sector, key R&D infrastructure and advanced manufacturing expertise making it…

Joint Statement on Skilled Migration Visa Changes

July 2017 Restoration on skilled visas welcomed across medical technology, biotechnology and pharmaceutical sector. The restoration of key occupations for the medical technology, research and pharmaceutical sector to the skilled migration visa list has been welcomed by six…

BioMelbourne Network Welcomes Revisions to Skilled Migration Visas

July 2017 Revisions to the skilled migration list have been welcomed by many BioMelbourne Network members across the biotechnology, medical technology and pharmaceutical sector. The restoration of occupations such as life scientist, biotechnologist, CEO/General Manager, and biochemist to…

LBT TO DISTRIBUTE APAS® IN AUSTRALIA & NZ

Australian medical technology company LBT Innovations Limited (ASX: LBT) has been appointed by joint venture company Clever Culture Systems AG (CCS) as the distributor for APAS® Independence in Australia and New Zealand. This will see LBT as the…

10th July – BioBriefing – US Regulatory Landscape: Hills and Valleys at FDA

Monday 10th July – 4:00 pm – 6:00 pm Dr Mary Beth Henderson is the Senior Principal Advisor in Regulatory Affairs and Quality Systems at US based RCRI® (Regulatory & Clinical Research Institute, Inc.). Dr Henderson will be…

20th June – PharmaMedtech Stories – Join the Conversation!

FREE Seminar and Q&A Session The Department of Industry, Innovation and Science’s Entrepreneurs’ Programme is pleased to announce a panel seminar and Q and A session with key experts in the Biotech/Medtech/Pharma Sector. This event is open for…

Home

News & opinion

Member Directory

Events